loader image
Monday, February 2, 2026
73.7 F
McAllen
- Advertisement -

LEARN MORE ABOUT DR. BILAL BIN HAFEEZ

Translate to Spanish or other 102 languages!

Graduate research assistants Emmanuel Anning, Godwin Peasah-Darkwah and Asif Shahriar work in the lab to assist in the development of a treatment for advanced pancreatic cancer. (UTRGV Image Office of Research & New Program Development)

Mega Doctor News

- Advertisement -

Hafeez is the founding member of the first nationally recognized South Texas Center of Excellence in Cancer Immunology at the UTRGV School of Medicine and is an accomplished researcher with a background in immunopharmacology, cancer therapeutics and cancer biology. Hafeez, a Nehtaur, Bijnor, Uttar Pradesh, India native, has earned prestigious grant awards and is an active member of the American Association for Cancer Research and the Indian Association for Cancer Research. His significant contributions to cancer biology and molecular therapeutics have led to his numerous published manuscripts in scientific journals. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Five Key Facts About AMD That Could Preserve Your Sight

Mega Doctor News By American Society of Retina Specialists Newswise - CHICAGO - Age-related macular...

Researchers Develop Blood Test to Spot Early-Stage Cancers with High Accuracy

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, rather than the absolute level of those patterns as in other liquid biopsies.

7 Everyday Changes That Make a Big Difference for Your Heart

Mega Doctor News By American Heart Association Everybody wants a healthy heart. But...

Spanish researchers eliminate pancreatic tumors in mice using a three-drug therapy

A team of scientists at the Centro Nacional de Investigaciones Oncológicas (CNIO) has reported the complete elimination of pancreatic tumors in mice using a combination of three targeted drugs.
- Advertisement -
×